Company news
Ryvu Therapeutics SA news in 2023
Ryvu Therapeutics SA's news releases, calls and decks from 2023, newest first.
Ryvu Therapeutics - Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes
October 23, 2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Solid Tumors and AML/HR-MDS, and Presents the Updated Development Plan for RVU120
October 23, 2023
Decks in 2023
- Investor Presentation (November 2023)
Investor deck · 44 slides · November 2023
- Investor Presentation (October 2023)
Investor deck · 44 slides · October 2023
- Investor Presentation (September 2023)
Investor deck · 41 slides · Sep 19, 2023